ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000234817.2	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.000343756	Resistant
ENSG00000234817.2	ABT-263 (navitoclax)	Ovarian serous cyStomach adenocarcinomaenocarcinoma	0.043809911	Resistant